IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
| Revenue (Most Recent Fiscal Year) | $3.90B |
| Net Income (Most Recent Fiscal Year) | $887.87M |
| PE Ratio (Current Year Earnings Estimate) | 51.22 |
| PE Ratio (Trailing 12 Months) | 53.76 |
| PEG Ratio (Long Term Growth Estimate) | 4.18 |
| Price to Sales Ratio (Trailing 12 Months) | 12.79 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 35.41 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 51.94 |
| Pre-Tax Margin (Trailing 12 Months) | 30.41% |
| Net Margin (Trailing 12 Months) | 24.41% |
| Return on Equity (Trailing 12 Months) | 64.42% |
| Return on Assets (Trailing 12 Months) | 29.89% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.11 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.79 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.31 |
| Inventory Turnover (Trailing 12 Months) | 3.98 |
| Book Value per Share (Most Recent Fiscal Quarter) | $19.48 |
| Earnings per Share (Most Recent Fiscal Quarter) | $3.63 |
| Earnings per Share (Most Recent Fiscal Year) | $10.67 |
| Diluted Earnings per Share (Trailing 12 Months) | $12.01 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 80.00M |
| Free Float | 79.22M |
| Market Capitalization | $51.66B |
| Average Volume (Last 20 Days) | 0.37M |
| Beta (Past 60 Months) | 1.56 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.98% |
| Percentage Held By Institutions (Latest 13F Reports) | 87.84% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |